Advances in the development of new biomarkers for Alzheimer’s disease

Abstract Alzheimer's disease (AD) is a complex, heterogeneous, progressive disease and is the most common type of neurodegenerative dementia. The prevalence of AD is expected to increase as the population ages, placing an additional burden on national healthcare systems. There is a large need f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Timofey O. Klyucherev, Pawel Olszewski, Alena A. Shalimova, Vladimir N. Chubarev, Vadim V. Tarasov, Misty M. Attwood, Stina Syvänen, Helgi B. Schiöth
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2022-04-01
Colecção:Translational Neurodegeneration
Assuntos:
Alzheimer's disease
Amyloid beta peptides
Biomarkers
Blood
Cytokines
Inflammation
Acesso em linha:https://doi.org/10.1186/s40035-022-00296-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados